Samuel Backenroth is CFO at Ohr Pharmaceutical Inc (OHRP). They have made 5 open-market trades across 2 companies since 2015, most recently 2023-03-31.
CIK 0001173281
5 open-market purchases totalling $131K since 2015, never a sale. Across 5 scored buys the stock is down 9.7% at ninety days, and 15.0 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 20% | 40% |
| Avg Move | -7.9% | -7.5% | -9.7% |
| Alpha | -7.4% | -10.9% | -15.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBSE | BUY | 2020-04-30 | 2020-05-04 | $6.00 | $6K | +1.0% | -2.8% | -4.7% |
| OHRP | BUY | 2017-04-10 | 2017-04-13 | $0.70 | $100K | -8.5% | -20.0% | -30.5% |
| OHRP | BUY | 2016-06-20 | 2016-06-21 | $2.84 | $7K | +1.5% | -3.5% | +0.4% |
| OHRP | BUY | 2016-05-23 | 2016-05-24 | $3.17 | $8K | +2.6% | -11.9% | -14.5% |
| OHRP | BUY | 2015-02-06 | 2015-02-10 | $6.75 | $10K | -35.8% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.